Duralax

Quick links to important sections

Duralax

Method of action: Laxative

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duralax

Property Description
Active ingredient Bisacodyl
Form Enteric-coated tablets, suppositories
Pharmacological class Stimulant laxative
Common use Relief of occasional constipation
Origin Synthetic diarylmethane derivative

What Type of Medicine is Duralax?

Duralax is a medicine whose active substance is Bisacodyl, which is classified pharmacologically as a stimulant laxative. It is a synthetic drug that functions as a prodrug, meaning it is biologically inactive upon consumption and is converted into its active form within the large intestine. This classification is supported by the fact that Bisacodyl promotes the accumulation of water and electrolytes in the colon, making stool easier to pass. The active ingredient is a diarylmethane derivative and is clinically recognized for its predictable action, leading to its inclusion on the World Health Organization’s List of Essential Medicines.


Composition and Available Forms

Historically, the composition of Duralax has been based on a single active ingredient, Bisacodyl, delivered in two primary dosage forms: the enteric-coated tablets for oral administration and the suppositories for rectal administration. The distinctive feature of the tablet form is its specialized coating, which prevents the drug from dissolving prematurely in the stomach, ensuring the Bisacodyl reaches the large intestine intact for activation. Studies confirm that Bisacodyl has minimal systemic absorption, meaning its action is primarily local to the colon, minimizing effects elsewhere in the body.


General Purpose and Action Principle

The general purpose of Duralax is to reliably and efficiently relieve occasional constipation and to facilitate complete bowel preparation required before diagnostic medical procedures, a use that is well-established in clinical practice. It achieves this benefit through two core actions localized in the colon: stimulating the muscle movement (peristalsis) in the large intestine wall, and encouraging the net secretion and retention of water and electrolytes. This dual mechanism ensures contents are moved effectively, translating into a consistent functional benefit for temporary bowel sluggishness.

Regulatory References

  1. MedlinePlus: Bisacodyl
  2. World Health Organization’s List of Essential Medicines

What side effects are possible with Duralax?

Possible Side Effects and Safety Information

Duralax (bisacodyl) is a stimulant laxative whose documented safety profile is based on regulatory data and is structured by frequency and severity of adverse reactions.

Common and Uncommon Adverse Reactions

The most commonly reported adverse reactions are related to gastrointestinal function, including abdominal cramps, abdominal pain, diarrhea, and nausea.

Uncommon reactions include vomiting, dizziness, abdominal discomfort, and anorectal discomfort. The occurrence of blood in the stool (haematochezia) is also an uncommon, generally mild, and self-limiting finding.

Serious and Clinically Significant Reactions

Rare but serious adverse reactions documented in regulatory sources include anaphylactic reactions (a severe allergic reaction), angioedema, and colitis (including ischaemic colitis). Syncope (fainting) may also occur rarely, often associated with a vasovagal response to abdominal spasm or defecation, rather than a direct drug effect.

Fluid and electrolyte imbalance, particularly hypokalaemia (low potassium), is a significant risk with prolonged or excessive use. This can lead to dehydration, muscle weakness, and increased sensitivity to other medications like cardiac glycosides.

Safety Restrictions and Contraindications

Duralax should not be used if an individual has ileus (intestinal obstruction), severe dehydration, acute abdominal conditions (such as acute appendicitis or inflammatory bowel diseases), or severe abdominal pain accompanied by nausea and vomiting.

Prolonged daily use is not advised, as it can lead to functional dependence for bowel movements. Individuals who experience dizziness or syncope should avoid potentially hazardous tasks like driving. Patients with conditions like anal fissures or ulcerative proctitis should use suppositories only with medical guidance due to the risk of local irritation. The oral tablets should not be taken within one hour of consuming milk or antacids, which can prematurely dissolve the tablet's protective coating.

Overdose and Emergency Response

The regulatory profile for Duralax (Bisacodyl) overdose is strictly defined by the consequences of excessive laxative effects on the gastrointestinal and metabolic systems. The official labeling documents manifestations of both acute overdose and chronic misuse.

Documented Overdose Manifestations

Acute overdose, resulting from high doses, presents with severe watery stools (diarrhoea), intense abdominal cramps, and a significant loss of fluid and electrolytes. Chronic excessive use is associated with more severe, long-term systemic outcomes such as persistent dehydration, hypokalaemia (low potassium), metabolic alkalosis, and potential complications like renal tubular damage.

When Immediate Medical Help is Required

The official labeling mandates that individuals seek immediate medical attention or go to the hospital straight away if more than the recommended dose has been taken. Emergency services must be contacted immediately if a person collapses or experiences a seizure, as these may signal life-threatening electrolyte disturbances.

Officially Documented Management

Management of bisacodyl overdose is officially described as supportive and symptomatic therapy, as there is no specific antidote known. Treatment focuses on preventing further absorption (such as through gastric lavage) and the critical replacement of fluids and correction of electrolyte imbalance. This replacement is deemed especially important in the elderly and the young due to their increased vulnerability to dehydration complications.

Therapeutic Uses of Duralax

Quick Facts: Uses of Duralax

  • Addresses Occasional Constipation: Intended for the temporary relief of infrequent bowel movements.
  • Supports Bowel Preparation: Used under medical direction to cleanse the bowel before certain diagnostic tests or procedures.
  • Facilitates Defecation: May be used in clinical circumstances that require easier or managed bowel evacuation.

Duralax is a medication indicated for the management of occasional constipation and irregularity. Its therapeutic goal is to support the body in producing a normal bowel movement. The treatment is appropriate for temporary use when addressing infrequent constipation.

In addition to addressing occasional constipation, Duralax is utilized under the supervision of a healthcare professional as part of the preparation for diagnostic procedures, such as a colonoscopy or radiological examination of the colon. The compound is also applied in pre- and postoperative settings, as well as for other medical conditions where the facilitation of defecation is required for patient care or recovery.

This medication should be used as directed by a healthcare provider, and prolonged use is not typically recommended.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Duralax (Bisacodyl)

The official eligibility profile for Duralax, as documented by regulatory agencies, defines specific populations who are permitted or restricted from its use.

Contraindicated Populations

Use is strictly contraindicated for individuals with known hypersensitivity to Bisacodyl, intestinal obstruction, ileus, acute abdominal conditions (including acute appendicitis and severe abdominal pain with vomiting), severe dehydration, or acute inflammatory bowel diseases

. Additionally, those with rare hereditary intolerances to excipients found in the tablet form (e.g., fructose intolerance) are prohibited from use.

Age and Special Population Restrictions

Population Eligibility Status (Regulatory Wording)
Adults (18+), Adolescents (12-17) Permitted for short-term use.
Children (10 years and under) Conditional Use; chronic constipation must be managed under the guidance of a physician.
Children (Under 4 years) Not Recommended/Contraindicated for most standard forms.
Pregnancy/Lactation Restricted Use; generally not recommended (especially first trimester) unless necessary and only on medical advice.

Continuous daily use is restricted and requires investigation into the cause of constipation. Use in older adults with fluid loss risk requires medical supervision.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile of Duralax (Bisacodyl) is structured around preventing disruption of the enteric coating of the oral tablet and managing the risk of electrolyte imbalance associated with stimulant laxative use. This information is based on official government regulatory documents.


Timing-Based and Gastrointestinal Interactions

The oral enteric-coated tablets require separation from substances that reduce stomach acidity to prevent premature dissolution, which can lead to gastric irritation. Mandatory time separation is required for the following products:

  • Antacids and Proton Pump Inhibitors (PPIs): Do not take the oral tablet within one hour of administering these acid-reducing medicines.
  • Milk or Dairy Products: The oral tablet must not be consumed within one hour of ingesting milk or dairy products.

Pharmacodynamic and Electrolyte-Altering Interactions

The concurrent use of Duralax with medicines that affect potassium levels increases the risk of hypokalaemia (low potassium) if the laxative is used excessively or chronically:

  • Diuretics (Potassium-Lowering) and Adrenocorticosteroids: Co-administration with these agents increases the potential for significant electrolyte imbalance.
  • Cardiac Glycosides (e.g., Digoxin): Hypokalaemia caused by laxative misuse or interacting medicines can lead to increased sensitivity to the toxic effects of cardiac glycosides.

Mechanism of Action

The action of Duralax begins in the large intestine where the inactive compound, Bisacodyl, is converted by local enzymes into its active metabolite, Bis-(p-hydroxyphenyl)-pyridyl-2-methane ( BHPM), which leads to a localized effect on the large intestine.

Dual Mechanism: Motility Stimulation and Fluid Secretion

The active metabolite exerts its effect through two complementary biological actions. Firstly, it acts as a stimulant on the nerve endings of the Enteric Nervous System (ENS) embedded in the colon wall, initiating increased, coordinated muscle contractions known as High Amplitude Propagated Contractions ( HAPCs). Secondly, BHPM engages a secretagogue action on the colonic epithelial cells. It activates the cAMP signaling pathway, which drives the active secretion of Cl^- and water into the lumen and simultaneously inhibits the reabsorption of Na^+ and H2 O via channels like Aquaporin-3 ( AQP3).

Resulting Physiological Consequences

These two parallel mechanistic cascades converge to modify the functional state of the colon. The ENS stimulation significantly accelerates the transit time of contents, while the cAMP pathway modulation results in a net accumulation of fluid and electrolytes, increasing their hydration and increasing their bulk. The combined pro-motility and volume-enhancing actions contribute to the drug's observed physiological effect.

Dosage and Administration Information

Duralax is administered by two official routes: the oral route, available as delayed-release tablets, and the rectal route, available as suppositories or enemas. The oral dosage is typically taken as a single daily dose, often at bedtime, to produce an effect 6 to 12 hours later. The standard adult oral dose, for individuals 12 years and older, ranges from 5 mg to 15 mg in a 24-hour period. Rectal administration uses a 10 mg suppository dose for adults and acts more rapidly, typically within 15 to 60 minutes of placement.

The administration of the oral tablets requires adherence to specific labeled constraints to ensure the medication functions as intended. The tablets are delayed-release and must be swallowed whole, without being crushed, chewed, or cut. Furthermore, the oral tablets should not be taken within one hour of consuming milk or antacids, as these substances can lead to the premature breakdown of the protective enteric coating. Dosing is adjusted for pediatric patients aged 6 to 11 years, who are given a single daily dose of 5 mg regardless of the administration route. The usage pattern for this medicine is strictly limited to short-term, intermittent relief; use should not exceed a maximum of seven days for the management of occasional constipation.

Recent Clinical Evidence

Research evidence / Overview of Studies for Duralax


Evidence for Use in Occasional Constipation Relief

The research exploring the use of Duralax for temporary constipation relief includes a base of short-term randomized controlled trials (RCTs) and scientific reviews. These studies primarily examine adult populations, including some research focused on older adults. Researchers were interested in how the medicine was studied for episodic or acute changes in bowel function. The outcomes research examined included measurements of the time elapsed until the first observed bowel movement, the frequency of movements, and characteristics of the stool, often using patient-reported scales.

Studies reported how outcomes related to physical discomfort were measured in the observed populations over defined, short time intervals, typically ranging from one day up to seven days. Findings describe patterns observed in the studies related to the time to the first bowel movement.

Evidence for Use in Bowel Preparation

Research concerning Duralax's role in bowel preparation, which is required before certain diagnostic procedures, includes comparative studies and RCTs. These studies primarily included adult patients preparing for procedures like colonoscopy. The studies explored outcomes centered on the quality of colon cleansing, which is measured using standardized clinical scales to ensure the procedure can be successfully completed.

Trials reported measurements of the colon cleansing quality achieved during the study period. The evidence is derived from studies focused on specific procedural efficacy outcomes, rather than the medicine's effect on general constipation.


What Remains Uncertain in the Research

According to scientific reviews, the evidence is limited concerning the long-term use of Duralax, as research has mainly explored its effects on acute, temporary symptoms. Data are still emerging for some specific patient groups with complex conditions. Furthermore, due to the nature of the studies, comparative evidence against all alternative treatments is sometimes lacking. Study results reflect group patterns, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Bisacodyl Tablet, Enteric Coated; Suppository (DailyMed Monograph)

Frequently Asked Questions (FAQ)

Common questions about Duralax (FAQ)


Q: How quickly does Duralax start to work?

Official product information indicates that the oral tablets generally produce a bowel movement within 6 to 12 hours. The rectal suppositories act more quickly, typically starting to work within 15 to 60 minutes of use. The difference in onset time relates to the route of administration and where the medicine is activated in the body.


Q: What is the difference between Duralax and similar over-the-counter options?

Duralax is officially classified as a stimulant laxative, which means it works by encouraging muscle movement in the colon and increasing fluid retention. This is distinct from other over-the-counter options, such as bulk-forming or osmotic laxatives, which are classified differently based on their primary mechanism for relieving temporary constipation.


Q: What happens if a dose of Duralax is missed?

If a dose of the medicine is forgotten, the instruction is to skip the missed dose and take the next dose at the usual scheduled time. Regulatory documents describe that a double dose should not be taken to make up for a forgotten dose.


Q: Is Duralax the same as a stool softener?

Duralax is officially a stimulant laxative. While it helps soften stool by promoting fluid accumulation in the colon, its primary classification is based on its mechanism of stimulating the muscle walls of the large intestine. Stool softeners are a separate class of medicines that primarily work to incorporate water into the stool.


Q: Is a person allowed to take Duralax on an empty stomach?

Official drug labels do not generally provide a specific instruction about taking the tablets with or without food. However, it is mandatory not to take the oral tablets within one hour of consuming milk or antacids, as these substances can interfere with the medicine's protective coating.


Q: Can Duralax be crushed or split?

The oral tablets are specially formulated as delayed-release and must be swallowed whole. They should not be chewed, crushed, or cut. This instruction ensures the protective coating remains intact until the medicine reaches the large intestine, which helps prevent stomach discomfort.


Q: What does the 'mechanism of action' for Duralax mean in simple terms?

The mechanism of action describes how the medicine works inside the body. In simple terms, Duralax is activated in the large intestine where it performs two actions: it encourages the muscles of the intestine to contract more, and it helps the intestine retain more water and salts. These actions work together to support an easier and more consistent bowel movement.


Q: Can Duralax be used for long-term support?

Regulatory guidance specifies that this medicine is intended only for short-term, temporary relief of occasional constipation. Use beyond seven days is a duration that may warrant discussion with a health professional to determine the underlying cause of constipation.


Q: Does Duralax cause any feeling of dependency?

Regulatory warnings indicate that prolonged daily use of stimulant laxatives may be associated with the body becoming functionally dependent on the medicine for bowel movements. Duralax is intended for intermittent use only.


Q: Does Duralax affect blood pressure?

Official documents do not list a direct effect on blood pressure. However, severe dehydration, which is a risk with the overuse or misuse of Duralax, may lead to an imbalance of fluid and electrolytes, which can cause symptoms such as dizziness or fainting (syncope).


Q: What should I do if Duralax doesn't seem to be working?

Official labeling describes that if an individual fails to have a bowel movement after using the laxative, use should be discontinued and a health professional consulted. This is to check for potentially serious conditions that may need assessment.


Q: Does Duralax have any documented interactions with herbal supplements?

Official guidance suggests that there is not enough scientific information to confirm whether all herbal remedies or supplements interact with Duralax. Individuals should consider informing a health professional about any herbal products they are taking due to the lack of specific data.


Q: How does Duralax compare to natural remedies?

Duralax is a chemically defined, classified stimulant laxative. Some regulatory bodies note that Duralax is considered therapeutically equivalent to the natural substance senna, which is also categorized as a stimulant laxative on the World Health Organization’s List of Essential Medicines.


Q: Does Duralax impact the absorption of vitamins or nutrients?

Official summaries indicate that prolonged or excessive use of Duralax may be associated with reduced absorption of certain fat-soluble vitamins (A, D, E, K) and minerals like calcium. This is due to its effect on the gastrointestinal tract.


Q: Is there a maximum amount of time Duralax can be used?

Official documentation states that for the temporary relief of occasional constipation, use should not exceed seven days without further medical evaluation. The medicine is intended only for short-term symptom relief.


Q: Can Duralax cause a headache?

Yes, headache is noted in some official patient information leaflets as a possible side effect of Duralax. It may also be associated with dehydration and fluid imbalance if the medicine is used excessively.


Q: Does Duralax contain any gluten or common allergens?

Duralax oral tablets contain certain inactive ingredients, including lactose and sucrose, and are reported in some official summaries to be free from gluten. Individuals with known sensitivities are directed to review the full list of inactive ingredients on the product labeling.


Q: Does Duralax cause dehydration?

Official warnings state that severe dehydration is a contraindication for use. The risk of dehydration and fluid imbalance increases with the prolonged or excessive use of Duralax. Signs of dehydration are a reason to discontinue use and seek advice.


Q: What if I experience a side effect not listed in the patient information?

Regulatory guidance and patient information state that suspected adverse reactions should be reported to a health professional or directly to the national reporting scheme, such as the FDA MedWatch program. This process ensures data is collected on potential unknown side effects.


Q: Can people who are lactose intolerant take Duralax?

Duralax oral tablets contain lactose. Official documentation states that patients with rare hereditary conditions of galactose intolerance, such as galactosaemia, should not take this medicine.


Q: How long does the effect of Duralax usually last?

The duration of the therapeutic effect is defined by the time it takes to produce a bowel movement (6-12 hours for oral tablets; 15-60 minutes for suppositories). The action is typically limited to a single bowel movement or a short series of movements related to the treatment.


Q: Is Duralax safe to use while breastfeeding?

Based on official reviews, the medicine is generally considered to be compatible with breastfeeding. This is because Duralax is not significantly absorbed from the digestive tract and its active metabolite is not typically detectable in breast milk.


Q: Can Duralax be used by people with heart conditions?

Regulatory guidance includes a warning regarding the concurrent use of Duralax with cardiac glycosides (a class of heart medicines). Misuse or overuse of Duralax can cause low potassium levels, which is associated with an increased risk of side effects from cardiac glycosides.


Q: Are there any common reasons Duralax might not be recommended for a patient?

Duralax is not recommended for individuals with intestinal obstruction, severe dehydration, acute abdominal conditions (like appendicitis), or severe abdominal pain accompanied by nausea and vomiting. These conditions are considered contraindications in regulatory documentation.


Q: How is Duralax classified by health authorities?

Health authorities officially classify Duralax as a stimulant laxative. Its recognized therapeutic role is confirmed by its inclusion on the World Health Organization’s List of Essential Medicines.


Q: Are there reports of Duralax interfering with birth control?

Authoritative guidance indicates that Duralax itself does not affect the effectiveness of hormonal contraception. However, if severe diarrhea occurs for more than 24 hours, the protection provided by oral contraceptive pills may be reduced.


Q: Is it possible to take Duralax every day?

Prolonged daily use of this medicine is not advised. Regulatory guidance specifies that use should not exceed a maximum of seven days for the management of occasional constipation. The medicine is intended for short-term, intermittent use only.


Q: Does Duralax have a taste or smell?

The active ingredient, Bisacodyl, is physically described in some sources as being tasteless. The oral tablets are covered with a delayed-release coating and should not be chewed or crushed to maintain its efficacy and prevent stomach irritation.

How should Duralax be stored and disposed of?

Duralax (bisacodyl) must be stored and disposed of according to specific regulatory requirements to maintain product integrity and ensure public safety.

Storage Conditions

Bisacodyl should be stored at a controlled room temperature, typically between 20°C and 25°C (68°F and 77°F). It is mandatory to protect the medicine from excessive humidity and heat. Suppositories, in particular, must not be stored above 30°C (86°F).

To ensure stability, the product must be kept in its original container, and you must not use individual blister units that are open or torn.

Disposal and Child Safety

All regulatory labeling requires Duralax to be stored out of the sight and reach of children.

For disposal of unused or expired medicine, official guidance advises utilizing a drug take-back program. If this is not available, the product should be mixed with an unappealing substance, sealed in a bag, and placed in the household trash. The medicine must not be flushed down the toilet or poured down the drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duralax found in:

A-Z Index: